Condor keeps repeating the same fantasy every cult stock repeats right before the blowup.
“The SEC hasn’t acted, so the company must be clean.” That logic is childish.
OTC Pink companies aren’t monitored in real time.
The SEC does not pre-approve filings, pre-validate numbers, or issue commentary on every violation.
They step in only when a pattern becomes large enough, or when a whistleblower packet lands on the right desk.
The idea that “SEC silence equals innocence” is the kind of fairy tale you tell bagholders to keep them docile.
The SEC doesn’t announce investigations. They don’t warn offenders. They don’t send courtesy memos. The first sign is usually a suspension or a federal complaint.
Meanwhile, nothing in AABB’s filings supports Condor’s claim that the company is doing “nothing wrong.”
The filings show dilution, fabricated assets, unexplained IP valuations, disappearing liabilities, and a balance sheet that grows only when they print more shares.
He wants people to believe the absence of immediate enforcement means the violations don’t matter.
In reality, it means he doesn’t know how OTC regulation works, but we knew that already.
When the filings already show this much rot, the clock doesn’t stop because Condor is impatient. The clock giggles, like everyone else.